Join
Live feed
·
INSIDERFilingvia Quantisnow
ACADIA Pharmaceuticals Inc. logo

EVP, Head of Research & Dev Thompson Elizabeth H.Z. converted options into 32,272 shares and sold $432,663 worth of shares (16,558 units at $26.13) as part of a pre-agreed trading plan, increasing direct ownership by 479% to 18,994 units (SEC Form 4) (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACAD (ACADIA Pharmaceuticals Inc.) and more on Quantisnow.